A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition: Malignant Melanoma, NeoplasmsInterventions: Drug: tizanidine; Drug: vemurafenibSponsor: Hoffmann-La RocheCompleted - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials